Home › Drug Codes › Q Codes › Q5175 · Immgolis
Upcoming code Effective Jan 1, 2027

Immgolis Q Code: Q5175

Injection, golimumab-sldi, biosimilar, 1 mg Direct supervision

Start 7-day free trial
Effective Date
Jan 1, 2027
Q1 2027 · not billable before
Medicare Payment Limit
Not yet published
CMS hasn’t priced Q5175 yet
CMS Decision
New code
Third Quarter 2026
Billing Unit
1 mg
per HCPCS unit · from the CMS descriptor
NDCs
Not yet listed
Listed once CMS crosswalks Q5175
Upcoming HCPCS Code · Effective January 1, 2027 CMS established Q5175 in its Third Quarter 2026 HCPCS coding cycle. It is not valid on claims with dates of service before January 1, 2027. CMS has not yet published a payment limit for Q5175.

Code Overview

HCPCS Descriptor (CMS) Injection, golimumab-sldi, biosimilar, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
CMS supervision clause. Medicare recognizes Q5175 when the drug is administered under the direct supervision of a physician. It is not for use when the patient self-administers. Self-administered drug exclusions →
Effective Date January 1, 2027
CMS Decision New code · Q3 2026 cycle
Manufacturer Accord Biopharma
Route of Administration Subcutaneous/Intravenous
FDA Approval May 15, 2026 · 351(k)

About Immgolis

Immgolis (golimumab-sldi) is a product of Accord Biopharma, given by the subcutaneous/intravenous route. CMS has established Q5175, a Q Code for it, effective January 1, 2027.

Q5175 Pricing

Effective Jan 1, 2027 No published pricing

Q5175 is not yet effective and does not have published pricing.

No pricing-app account? Start a 7-day free trial · card required · cancel anytime

Code Timeline

  1. Third Quarter 2026 CMS establishes Q5175 Published in the CMS HCPCS application summary.
  2. Jan 1, 2027 Q5175 takes effect The code becomes billable. Immgolis’s launch date is set by its manufacturer and may come later.
  3. Once CMS has pricing data Medicare pricing CMS adds a payment limit to a quarterly ASP file. That can be the quarter the code takes effect or later.

Frequently Asked Questions

When can I start billing Q5175?
For dates of service on or after January 1, 2027. A claim dated earlier with Q5175 will deny. The effective date is when the code becomes valid, not necessarily when Immgolis is available.
What is the payment limit for Q5175?
CMS has not published one yet. A new code gets a payment limit in a quarterly CMS ASP file once CMS has pricing data for the drug, which can be the quarter the code takes effect or later. Until then, Medicare contractors price claims individually.
Can Q5175 be billed when the patient self-administers Immgolis?
No. The CMS descriptor limits the code to administration under the direct supervision of a physician.

Source: CMS HCPCS Application Summary, Third Quarter 2026 (PDF) . Code decisions are CMS’s; this page tracks them until the code takes effect.